Medac Gesellschaft fuer klinische Spezialpraeparate mbH
- Address
- Theaterstr. 6
Sponsor Overview
Specializations
Atopic Dermatitis
Clinical research in moderate to severe atopic dermatitis focuses on treatment response and skin symptom control in adult participants.
- Methotrexate
- Eczema Area and Severity Index
- Inflammatory skin disease
Interest in this area centres on improving disease activity and treatment effectiveness in chronic dermatologic care.
Acute Graft versus Host Disease
Trials address steroid-refractory acute graft-versus-host disease in adult, adolescent, and paediatric populations after allogeneic stem cell transplantation.
- Mesenchymal stromal cells
- Best available therapy
- Overall response rate
The therapeutic emphasis includes immune-mediated complications, treatment resistance, and post-transplant disease control.
Hematologic Malignancies
Research activity extends to patients with acute myeloid leukaemia and myelodysplastic syndrome undergoing haematopoietic stem cell transplantation.
- Leukaemia
- Myelodysplastic syndrome
- Transplant-related care
This area links oncology with transplant medicine and supportive management before and after cell-based procedures.
Transplantation Support and Safety
Additional clinical interest includes supportive treatment around stem cell transplantation, with attention to cardiac safety and tolerability of conditioning-related therapy.
- Treosulfan chemotherapy
- Conditioning regimens
- Peri-transplant safety
These studies reflect involvement in treatment settings where transplant preparation and complication monitoring are central to patient care.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Cardiac Safety of Treosulfan-Based Chemotherapy in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation |  Germany | Not Recruiting |
| Evaluation of Subcutaneous Methotrexate Efficacy and Safety Compared to Placebo in Adults with Moderate to Severe Atopic Dermatitis |  Czechia France Italy Poland | Not Recruiting |
| Phase 2 Multicenter Trial of Mesenchymal Stromal Cells MC0518 vs. Best Available Therapy in Pediatric Steroid-Refractory Acute Graft-Versus-Host Disease | France Germany Italy Poland Spain | Not Recruiting |
| Phase 3 Randomized Open-Label Study of Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Steroid-Refractory Acute Graft-Versus-Host Disease | France Germany Poland Spain | Recruiting |
Data & Insights
This sponsor works with 13 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 83 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases2 trials322 other sponsors
- 2.Hemic and Lymphatic Diseases1 trial249 other sponsors
- 3.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
83 centres- Address
- Ul. PCK 26, 33-100 Tarnow
- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- Via Cherasco 15, 10126 Turin
- Address
- Viale Antonio Gramsci 14, 43126 Parma
- Address
- Via Pietro Albertoni 15, 40138 Bologna
- Address
- Viale Michelangiolo 41, 50125 Florence
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Medac Gesellschaft fuer klinische Spezialpraeparate mbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.